NICE guidelines for chronic obstructive pulmonary disease--a review.
In the UK the prevalence of chronic obstructive pulmonary disease has been estimated at one per cent, rising to five per cent of men aged 65-74 years and 10 per cent of men aged over 75 years. It is thought that only a quarter of COPD cases are diagnosed (Calverley and Bellamy, 2000). The symptoms of breathlessness, chronic cough, and regular sputum production usually develop insidiously. However, COPD not only affects the lungs but has extra pulmonary effects such as muscle wasting and weight loss, pulmonary hypertension, cor pulmonale (enlargement of the right side of the heart), anxiety, and depression.
Fehrenbach
Christine
C
Portsmouth Hospitals NHS Trust.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001945:Breathing Exercises; D001993:Bronchodilator Agents / Q000627:therapeutic use; D006801:Humans; D024802:Nurse's Role; D010102:Oxygen Inhalation Therapy; D010166:Palliative Care; D010348:Patient Care Team; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D016540:Smoking Cessation; D013147:Spirometry; D006113:United Kingdom / Q000453:epidemiology
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents